The ATRYN Honor Program
The goal of this program is to assure that customers will only pay for the amounts (increments of 25%) of ATryn that is actually used. The ATryn Honor Program will 'honor' the self-reported usage from customers and will allow you to only pay for the amount of ATryn that is used.
If you use less than the full vial, we will issue you a credit towards the purchase of your next order of ATryn. The amount of credit will correlate with the amount of each vial used.
For example:
You order 10 vials of ATryn. In this lot, each vial contains 1750 IU. You use 500 IU from each of 5 vials, and 1000 IU each from the remaining 5 vials.
You will receive according to usage and credit table below a credit of 6565 IU (5vials X 875 IU credit) + (5 vials X 438 IU credit) towards your next ATryn order.
In that way, you pay for only the amount of product you use.
| Amount used (in units) | Credit Amount (in units) |
| 0001 - 0438 | 1313 (25% used) |
| 0439 - 0875 | 0875 (50% used) |
| 0876 - 1313 | 0438 (75% used) |
| 1314 - 1750 | 0000 (100% used) |
Note: The actual number of units will vary by lot.
Please contact the following distributors for more information:
- ABO Pharmaceuticals
- 7930 Arjons Drive, Suite A
- San Diego, CA 92126
- 877-226-2266
- www.abopharmaceuticals.com
- ASD Healthcare
- 3101 Gaylord Parkway, 3rd Floor
- Frisco, TX 75034
- 800-746-6273
- www.asdhealthcare.com
- BDI Pharma
- 120 Research Drive
- Columbia, SC 29203
- 800-948-9834
- www.bdipharma.com
- BioCARE
- 4505 E. Cotton Center Blvd., Suite 100
- Phoenix, AZ 85040
- 800-304-3064
- www.biocare-us.org
- Cardinal Health SPD
- 305 Tech Park Drive
- Suite 113
- La Vergne, TN 37086
- 866-476-1340
- www.cardinal.com/spd
- FFF Enterprises, Inc.
- 41093 County Center Drive
- Temecula, CA 92591
- 800-843-7477
- www.fffenterprises.com
- McKesson Plasma and BioLogics, LLC
- 401 Mason Road
- La Vergne, TN 37086
- 877-625-2566
- www.mckesson.com
- National Hospital Specialties (NHS)
- 65 Commerce Way
- Hackensack, NJ 07601
- 800-344-6087
- www.nhsusa.com
- Novis Pharmaceuticals, LLC
- 5000 SW 75th Avenue
- Suite 121
- Miami, Florida 33155
- Phone: 800.727.6711
- www.novispharma.com
Ready when you need it
- ATryn is a sterile, lyophilized powder; each single-use vial contains the potency stated on the label, which is approximately 1750 IU1
- Store ATryn refrigerated between 2°C and 8°C (36°F and 46°F)1
References: 1. ATryn [package insert] Framingham, MA: GTC Biotherapeutics, Inc. ; April 2009.
Indications and Usage
ATryn is a recombinant antithrombin indicated for the prevention of peri-operative and peri-partum thromboembolic events in hereditary antithrombin deficient patients.
It is not indicated for treatment of thromboembolic events in hereditary antithrombin deficient patients.
Important Safety Information
ATryn is contraindicated in patients with known hypersensitivity to goat and goat milk proteins. Allergic-type hypersensitivity reactions, including anaphylaxis, are possible. Patients must be closely monitored and carefully observed for any symptoms throughout the infusion period. Patients should be informed of the early signs of hypersensitivity reactions including hives, generalized urticaria, tightness of the chest, wheezing, hypotension, and anaphylaxis. If these symptoms occur during administration, treatment must be discontinued immediately and emergency treatment should be administered.
The anticoagulant effect of drugs that use antithrombin to exert their anticoagulation may be altered when ATryn is added or withdrawn. To avoid excessive or insufficient anticoagulation, coagulation tests suitable for the anticoagulant used (e.g., aPTT and anti-Factor Xa activity) are to be performed regularly, at close intervals, and in particular in the first hours following the start or withdrawal of ATryn. Additionally, patients should be monitored for the occurrence of bleeding or thrombosis in such situations.
The serious adverse reaction that has been reported in clinical studies is hemorrhage (intra-abdominal, hemarthrosis, and post procedural). The most common adverse events reported in clinical trials at a frequency of =5% are hemorrhage and infusion site reaction.
For more information, please view full Prescribing Information for ATryn.
To report suspected adverse reactions contact GTC Biotherapeutics at 1-800-610-3776 or the FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.
For more information, please see full Prescribing Information for ATryn.
® ATryn is a registered trademark of GTC Biotherapeutics, Inc.
For medical inquiries, please
call 800-610-3776
or e-mail
medinfo@GTC-bio.com